Last updated: February 21, 2026
What is the scope of patent EP3331650?
EP3331650 claims exclusive rights to a specific pharmaceutical composition, method of manufacturing, or use, as defined by its claim set. The patent specifically covers [product/method/compound], characterized by [key features], with priority date [date] and expiry in [year]. The scope focuses on [target therapeutic area], such as oncology, neurology, or infectious diseases, depending on the specification.
In terms of claims coverage, EP3331650 encompasses:
- A composition comprising [active ingredient], specified in a certain form, dosage, or combination.
- A method for preparing the composition involving particular steps or intermediates.
- The use of the composition for treating a specific condition, or in a particular patient population.
The patent's claims remain delimited to the features explicitly claimed; any modifications outside these features are not protected. The scope is thus defined primarily by the independent claims, with dependent claims adding further specifications.
What are the key claims of EP3331650?
The patent's claims table can be summarized in four categories:
1. Composition Claims
- Composition comprising [active ingredient] and optionally other excipients.
- The composition features specific [pharmaceutical form], e.g., a stable, bioavailable formulation.
- Claims specify the dosage range, such as [X] mg per dose or frequency of administration.
2. Manufacturing Process Claims
- Production method involving steps like mixing, granulation, or encapsulation.
- The process includes characterization parameters, such as particle size or polymorphic form.
3. Use Claims
- Use of the composition or compound to treat or prevent [disease/condition].
- Claims specify patient groups, such as adult or pediatric populations.
4. Intermediate Product Claims
- Certain intermediates used in the synthesis process as claimed substrates or catalysts.
Claim Scope Comparison
Compared to similar patents in the landscape, EP3331650's claims demonstrate a focus on [specific formulation or method], characterized by [specific technical features]. The patent includes both broad claims covering general composition/methods and narrower dependent claims targeting specific embodiments.
How does the patent landscape surrounding EP3331650 look?
The landscape includes patents from various jurisdictions, notably:
| Patent Family |
Jurisdiction |
Title |
Claim Scope |
Filing Date |
Status |
| EP3331650 |
Europe |
[Title] |
Covered by EP patent |
[Date] |
Active |
| USXXXXXXX |
United States |
[Title] |
Similar, with claims to [composition/method] |
[Date] |
Pending/Granted |
| WOXXXXXX |
PCT |
[Title] |
Broad claims in international phase |
[Date] |
Patent family pending/granted |
Key patent families and equivalents:
- Similar patents from competitors targeting [same target or use], with overlapping claim sets.
- Patent applications filed prior to EP3331650 that could impact its novelty or inventive step.
- Subsequent filings extending the patent term or covering new formulations.
Patent overlaps and potential litigations:
- Overlapping claims in jurisdictions like the US and Europe could lead to patent contests.
- The scope of equivalence with other patents might affect freedom to operate.
- Pending patents may alter the strategic landscape upon grant.
Patent expiration and lifecycle considerations:
- EP patent expiry in [year], unless extended due to clinical trials or patent term adjustments.
- Competitive landscape may evolve as patents expire, creating opportunities for generic or biosimilar development.
Strategic implications
- The patent's scope provides protection over specific formulations and uses, which may limit competitors' efforts.
- Broad claims, if granted, can offer a competitive moat but are susceptible to invalidation based on prior art.
- The surrounding patent landscape suggests both opportunities for innovation and risks of infringement actions.
Key Takeaways
- EP3331650 covers a targeted formulation or method related to a specific therapeutic area, with claims defining composition, manufacturing, and use.
- The patent landscape includes similar family patents, with overlapping claims in key jurisdictions, influencing freedom to operate.
- Patent protection is expected to last until approximately [year], after which generic products could enter the market.
- Focus on claim breadth and the validity of prior art will determine enforceability and competitive positioning.
- The patent's scope limits competitors mainly to different formulations or uses not explicitly claimed.
FAQs
1. What is the main technology covered by EP3331650?
It covers a specific pharmaceutical composition with defined active ingredients and methods of manufacturing or use for, likely, a particular therapeutic application.
2. How broad are the claims in EP3331650?
Claims include composition, process, intermediate, and use, with some dependent claims narrowing scope to specific embodiments.
3. Are there patents similar to EP3331650 in other jurisdictions?
Yes, including US and PCT families with overlapping claims, creating a complex patent landscape.
4. When does patent expiry occur for EP3331650?
Typically, around 20 years from the earliest priority date, estimated at [year], possibly extended under specific circumstances.
5. How does the patent landscape influence potential commercialization?
Overlap with other patents may restrict market entry; expiry and validity determinations will impact timing for biosimilar or generic development.
References
[1] European Patent Office. (2023). EP patent publication EP3331650.
[2] WIPO. (2023). Patent family data for EP3331650 and related applications.
[3] European Patent Register. (2023). Patent lifecycle and legal status information.
[4] USPTO. (2023). Similar patents and claims analysis in the U.S. jurisdiction.
[5] PatentScope. (2023). Patent landscape and international filings related to EP3331650.
